section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cisatracurium besylate

(Mfr: SZ, ABV)(Conc: 2 mg/mL)

QMark

Alprostadil

(Mfr: PF)(Conc: 20 mcg/mLa)

Remarks:

Inconsistent results from subvisible particle analyses. Microparticulates detected by 1 of 3 methods in 4 hr at 20 to 22°Cp

Ref:

3976